¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

°Ç±¹´ëÇб³º´¿ø ¿µ»óÀÇÇаú 2019 APECS (Advances in Peripheral EndovasCular Strategies) : 2019-11-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
°Ç±¹´ëÇб³º´¿ø ¿µ»óÀÇÇаú 2019 APECS (Advances in Peripheral EndovasCular Strategies) : 2019-11-24
±³À°ÀÏÀÚ : 2019-11-24
±³À°Àå¼Ò : °Ç±¹´ëÇб³º´¿ø ´ë°­´ç(B3)  
±³À°ÁÖÁ¦ : 2019 APECS (Advances in Peripheral EndovasCular Strategies)      
ÁÖÃÖ±â°ü : °Ç±¹´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¿µ»óÀÇÇаú  
´ã´çÀÚ : ÇÔ»óÇù
¿¬¶ôó : 02-3144-2227  
À̸ÞÀÏ : apecsmeeting@gmail.com      
±³À°Á¾·ù : ¿µ»óÀÇÇаú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 30,000¿ø      
ºñ°í »çÀüµî·Ï½Ã µî·Ïºñ ¹«·á ÇöÀåµî·Ï½Ã Àü¹®ÀÇ:3¸¸¿ø, ±âŸ:1¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-24  09:00~09:10 How to assess treatment result for CVI?  Á¤ÇõÀç(ºÎ»êÀÇ´ë ¾ç»ê) 
±³À°½Ã°£ 11-24  09:10~09:20 Things you need to know when you begin US examination  ÀåÀϼö(¼ö¿µ»óÀÇÇÐ) 
±³À°½Ã°£ 11-24  09:20~09:50 Live Case 1. Thermal ablation  ¹Ú»ó¿ì,ȲÁøÈ£,±Ç¿ë¿ø,¹ÎÁö¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-24  09:50~10:00 What unique refluxes and unusual anatomical variations should we know during ultrasound?  ±è¹ÌÇü(°¡Å縯ÀÇ´ë ÀºÆò) 
±³À°½Ã°£ 11-24  10:00~10:10 Important meanings of US control panel: How to use them?  À¯ÈçÁ¦(ij³íÄÚ¸®¾Æ) 
±³À°½Ã°£ 11-24  10:10~10:20 Venous pain: How to differentiate and how to manage it?  ³ëȯ±Ô(ÇÏÆ®À£ÀÇ¿ø) 
±³À°½Ã°£ 11-24  10:20~10:30 APECS meets IVDT symposium : What venous issues were hot in the past IVDT?  Á¶ÁøÇö(°æÈñÀÇ´ë) 
±³À°½Ã°£ 11-24  10:30~10:50 Coffee break  () 
±³À°½Ã°£ 11-24  10:50~11:20 Live Case 2. Thermal ablation  ¹Ú»ó¿ì,ȲÁøÈ£,±Ç¿ë¿ø,¹ÎÁö¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-24  11:20~11:30 How to make standardization for EVLT regarding wavelength, LEED, and fiber tips?  À̰溹(¼­¿ïÀÇ·á¿ø) 
±³À°½Ã°£ 11-24  11:30~11:40 Can 1940nm laser overcome shortcomings of previous endovenous lasers?  ¹ÚÀμö(ÂüÇÏÁö¿Ü°ú) 
±³À°½Ã°£ 11-24  11:40~11:50 New radiofrequency catheter came up. What is different?  ¹Ú»ó¿ì(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-24  11:50~12:20 Live Case 3. Venaseal  ¹Ú»ó¿ì,ȲÁøÈ£,±Ç¿ë¿ø,¹ÎÁö¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-24  12:20~12:30 Do we still need to believe in the superiority of radiofrequency over EVLT since ¡°RECOVERY¡± study?  Â÷´ë¿ø(»ï¼ºÈäºÎ¿Ü°úÀÇ¿ø) 
½Ä»ç 11-24  12:30~13:10 Lunch  () 
±³À°½Ã°£ 11-24  13:10~13:50 Special Lecture: 2020³â °Ç°­º¸Çè Á¤Ã¥¹æÇâ (ÇÏÁöÁ¤¸Æ·ù¿Í Ç÷°üÃÊÀ½ÆÄ ÁúÀÇ ÀÀ´ä Æ÷ÇÔ)  ÀÌÁß±Ô(º¸°Çº¹ÁöºÎ º¸Çè±Þ¿©°ú) 
±³À°½Ã°£ 11-24  13:50~14:00 Hydrophilic guide wire is necessary to increase technical success of endovenous treatment?  È²ÁøÈ£(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-24  14:00~14:10 What hurdles do we tend to face during VenaSeal treatment? How to overcome them?  ±è°Ç¿ì(¹ÎÆ®º´¿ø) 
±³À°½Ã°£ 11-24  14:10~14:20 How to reduce and manage phlebitis or any other complications after VenaSeal  À̱æ¼ö(Á¦ÁÖ¼öÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11-24  14:20~14:30 Do we need to make even distribution of sclerosant during MOCA? How to increase technical or clinical success rate?  À̽Âö(ÆíÇÑÇÏÁöÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11-24  14:30~15:00 Live Case 4. MOCA  ¹Ú»ó¿ì,ȲÁøÈ£,±Ç¿ë¿ø,¹ÎÁö¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-24  15:00~15:10 What are the limitations or contraindications for MOCA?  °øÁØÇõ(¸ÞµðÇ÷º½º¼¼Á¾º´¿ø) 
±³À°½Ã°£ 11-24  15:10~15:20 How to select endovenous devices according to lesion characteristics  ±èÇâ°æ(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 11-24  15:20~15:30 Coffee break  () 
±³À°½Ã°£ 11-24  15:30~15:40 How to reduce infection related to PICC  ¿ÀÇàÁø(ÀÎÁ¦ÀÇ´ë ¼­¿ï) 
±³À°½Ã°£ 11-24  15:40~15:50 What are differences among many PICCs in Korea? What do we need to consider before picking up?  ¼Û¸í±Ô(°í·ÁÀÇ´ë ±¸·Î) 
±³À°½Ã°£ 11-24  15:50~16:00 Is subclavian vein really thrombogenic? Do we need to avoid it?  ±è¿ëÀç(¼øõÇâÀÇ´ë ¼­¿ï) 
±³À°½Ã°£ 11-24  16:00~16:10 What is the preliminary result of multicenter retrospective study regarding risk factors for PICC associated complications?  ±èÀÀÅÂ(ÇѾç´ëÇб³ ±¸¸®) 
±³À°½Ã°£ 11-24  16:10~16:20 No route in limb for hemodialysis: Hero and Surfacer can give us the solution.  ¾ç½ÂºÎ(¼øõÇâÀÇ´ë ±¸¹Ì) 
±³À°½Ã°£ 11-24  16:20~16:30 No route in limb for hemodialysis: Transrenal insertion of Perm-cath may serve as an alternative route  ½ÅÁöÈÆ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-24  16:30~16:40 Repair vs. exchange of malfunctioning perm-cath: Which one is better?  Á¶¼º±â(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-24  16:40~16:45 New PICC catheter development: KUH research result  ¹ÎÁö¿µ(°Ç±¹ÀÇ´ë) 
Åä·Ð 11-24  16:45~16:55 Discussion  () 
±âŸ 11-24  16:55~17:00 Closing Remark  ¹Ú»ó¿ì(°Ç±¹ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" °Ç±¹´ëÇб³º´¿ø ¿µ»óÀÇÇаú 2019 APECS (Advances in Peripheral EndovasCular Strategies) : 2019-11-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼­¿ï´ëº´¿ø 2019³âµµ ´ëÇѳúÀüÁõÇÐȸ °³¿øÀÇ ¿¬¼ö°­Á : 2019-11-24
´ÙÀ½±Û »ï¼º¼­¿ïº´¿ø 2019 ÀÌ°úÇÐ Live Surgery ¹× ½ÅÀÇ·á±â¼ú ¼¼¹Ì³ª : 2019-11-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 48 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 43 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 38 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 51 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 38 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 73 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 27 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 39 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 38 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 45 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 43 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 32 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 36 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 39 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 45 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷